Who are we?

Antegenes is an innovation-oriented Estonian health technology company founded in 2018. Antegenes is a healthcare provider of medical genetics, oncology and laboratory services registered by the Estonian Health Board. All our tests are registered as CE-marked medical devices (in vitro diagnostics, IVD). Our quality management system complies with the ISO 13485:2016 standard.

We have developed novel polygenic risk score based genetic tests to estimate the risk of common cancers. The polygenic risk score sums up information over hundreds to thousands of genetic variants in the human genome. By combining the polygenic risk score with a person’s background (origin, age, and gender), we can calculate a person’s risk of developing cancer and provide medical advice on prevention and early detection.

Our mission is to enable people to have a better, healthier, and longer life by helping individuals, healthcare professionals, and organizations use genetic information for personal and public health.

Featured in

Meet the team

  • Peeter Padrik, MD, PhD Founder & CEO peeter.padrik@antegenes.com
    As one of the leading cancer specialists in Estonia, doctor Peeter Padrik has...
  • Berit Kolk, MSc Chief Operating Officer / On Parental Leave berit.kolk@antegenes.com
    Berit Kolk is the chief operating officer and runs the daily operations of...
  • Siim Sõber, PhD Chief Product Officer siim.sober@antegenes.com
    Siim Sõber is the chief product officer at Antegenes. His academic work has...
  • Neeme Tõnisson, MD, PhD Medical Geneticist neeme.tonisson@antegenes.com
    Neeme Tõnisson is Antegenes’ team medical geneticist and laboratory physician. Neeme has defended...
  • Krista Kruuv-Käo, MD Business Development Manager krista.kruuv-kao@antegenes.com
    Krista’s responsibility is the business development of Antegenes. Starting from the successful establishment...
  • Roman Zahharov, MA Chief Financial Officer roman.zahharov@antegenes.com
    Roman holds a Master’s degree in Corporate Finance and has 20 years of...
  • Olar Teder, MBA Sales Director olar.teder@antegenes.com
    Olar Teder is the sales director at Antegenes with sales experience in various...
  • Jagnar Pindmaa Chief Technology Officer jagnar.pindmaa@antegenes.com
    Jagnar is the chief technology officer at Antegenes. He is hugely passionate about...
  • Anna Padrik, BA Marketing Manager anna.padrik@antegenes.com
    Anna is our marketing manager, who oversees all our marketing and communication activities....
  • Anette Paas, RN Nurse anette.paas@antegenes.com
    Anette is our registered nurse. She acquired her nursing degree at the Tallinn...
  • Kristi Kaljulind, BSc Quality Manager kristi.kaljulind@antegenes.com
    Kristi is the Quality Manager of Antegenes. Her main task is to ensure...
  • Regina Saar, MSc Bioinformatician / On parental leave regina.saar@antegenes.com
    Regina is our bioinformatician. She has a degree in genetic engineering and advanced...
  • Jana Jõgi, MSc Quality Manager / On parental leave jana.jogi@antegenes.com
    Jana Jõgi is the Quality Manager of Antegenes. Her main task is to...

Advisory board

  • Akshay Mody, MD
    Akshay Mody has spent over 20 years in the healthcare industry. His most...
  • Gareth Evans, MB, BS, MD, FRCP, FLSW, FRCOG, ad eundem
    A Consultant at Manchester University Hospitals NHS Foundation Trust and The Christie NHS...
  • James Mackay, MD
    Dr James Mackay has been practicing as a Consultant Genetic Oncologist for over...
illustration

Why Antegenes?

“During my career as a doctor, I have seen and treated, in the team with my colleagues, thousands of cancer patients. We have been able to cure many of them. We have been able to give additional life to majority of them. But also, we have not been able to cure completely many of them. We have implemented many new effective cancer therapies and improved the quality of cancer care. But all the time I have been aware that the best cancer cases are these we could avoid. Or, if this is impossible to prevent, we could detect as early as possible, to implement as effective therapy as possible.

As cancer is a genetic disease, developments in basic research have opened new avenues for us to use genetic information in the prevention and early detection of cancer. With these developments, I became aware that we have to implement this new genetic information into cancer prevention as well as possible. To develop and achieve that, also, Antegenes as an organization was born. As the same genetic and clinical principles also apply for other complex diseases, we have also included these into our developments. For people, after all, are essential their general good health and longevity, not so much single diseases.”

  • Peeter Padrik, MD, PhD Founder & CEO

Trusted by healthcare institutions across Europe